20002020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 1 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Research Output

Androgen decline and survival during docetaxel therapy in metastatic castration resistant prostate cancer (mCRPC)

From The Alliance for Clinical Trials in Oncology Genitourinary Committee, Mar 1 2020, In : Prostate Cancer and Prostatic Diseases. 23, 1, p. 66-73 8 p.

Research output: Contribution to journalArticle

Open Access
  • 1 Scopus citations

    Androgens and Overall Survival in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Docetaxel

    The Alliance for Clinical Trials in Oncology Genitourinary Committee, Jun 2020, In : Clinical Genitourinary Cancer. 18, 3, p. 222-229.e2

    Research output: Contribution to journalArticle

  • A review of prostate cancer treatment impact on the CNS and cognitive function

    Ryan, C., Wefel, J. S. & Morgans, A. K., Jun 1 2020, In : Prostate Cancer and Prostatic Diseases. 23, 2, p. 207-219 13 p.

    Research output: Contribution to journalReview article

    Open Access
  • Diet and lifestyle considerations for patients with prostate cancer

    Zuniga, K. B., Chan, J. M., Ryan, C. J. & Kenfield, S. A., Mar 2020, In : Urologic Oncology: Seminars and Original Investigations. 38, 3, p. 105-117 13 p.

    Research output: Contribution to journalReview article

  • 1 Scopus citations

    Editorial: Androgen hazards with COVID-19

    Sharifi, N. & Ryan, C. J., Jan 1 2020, In : Endocrine-related cancer. 27, 6, p. E1-E3

    Research output: Contribution to journalReview article

    Open Access
    1 Scopus citations

    Press / Media

    Cancer death rates are going down. Is prostate cancer an exception?

    Charles Ryan

    2/4/20

    1 item of Media coverage

    Press/Media: Expert Comment